Expand AKBA Menu
AKBA MENU

AKBA Latest Press Releases

-- March 19, 2026 --

Akebia Therapeutics to Host Virtual R&D Day Highlighting Robust Kidney Disease Pipeline, on April 2, 2026 Globe Newswire 4:05 PM

-- March 3, 2026 --

Akebia Therapeutics to Present at the Leerink Partners 2026 Global Healthcare Conference Globe Newswire 8:00 AM

-- March 2, 2026 --

Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 4:05 PM

-- February 26, 2026 --

Akebia Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Commercial and Pipeline Highlights Globe Newswire 7:00 AM

-- February 19, 2026 --

Akebia Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results and Discuss Recent Business Highlights Globe Newswire 8:00 AM

-- February 4, 2026 --

Akebia Therapeutics to Present at the Guggenheim Emerging Outlook: Biotech Summit 2026 Globe Newswire 8:00 AM

-- February 2, 2026 --

Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 4:05 PM

-- January 12, 2026 --

Akebia Therapeutics Announces Corporate Updates and 2026 Pipeline Outlook Globe Newswire 8:00 AM

-- January 6, 2026 --

Akebia Therapeutics Announces First Patient Dosed in Phase 2 Clinical Trial of Praliciguat for the Treatment of Focal Segmental Glomerulosclerosis (FSGS) Globe Newswire 8:00 AM

-- January 5, 2026 --

Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 4:05 PM

-- December 1, 2025 --

Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 4:05 PM
Q32 Bio Sells Complement Inhibitor ADX-097 PRNewswire 7:00 AM
Akebia Announces Establishment of Rare Kidney Disease Pipeline Globe Newswire 7:00 AM

-- November 24, 2025 --

Akebia Therapeutics to Present at the Piper Sandler 37th Annual Healthcare Conference Globe Newswire 8:00 AM

-- November 10, 2025 --

Akebia Therapeutics Reports Third Quarter 2025 Financial Results and Recent Business Highlights Globe Newswire 7:00 AM

-- November 6, 2025 --

Vafseo (vadadustat) Dialysis Dependent Patient Post Hoc Data Analysis: Composite of All-Cause Mortality and Hospitalization Outcomes Statistically More Favorable for Patients Receiving Vadadustat vs. ESAs Globe Newswire 6:30 PM

-- November 4, 2025 --

Akebia Therapeutics to Present at Upcoming Investor Conferences Globe Newswire 8:00 AM

-- November 3, 2025 --

Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 4:05 PM

-- October 30, 2025 --

Akebia Therapeutics to Report Third Quarter 2025 Financial Results and Discuss Recent Business Highlights Globe Newswire 8:00 AM

-- October 28, 2025 --

Akebia Therapeutics Provides Update on Vafseo for Non-Dialysis Patients Globe Newswire 4:30 PM
Market Data Delayed 15 Minutes